Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 18 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Acid suppression improves sleep in minimally symptomatic GERD patients

This month's Digestive Diseases and Sciences examines GERD as an etiology of sleep disturbance in subjects with insomnia and minimal reflux symptoms.

News image

fiogf49gjkf04

Gastroesophageal reflux disease (GERD) is a well-recognized cause of impaired sleep in patients with frequent GERD symptoms, as well as those with sleep apnea.

GERD's role in sleep disturbance of minimally symptomatic patients with poor sleep quality is less clear.

After 2 weeks of treatment, 19% had normalization of sleep efficiency
Journal Digestive Diseases and Sciences

Dr Nicholas Shaheen and colleagues from North Carolina, USA explored the prevalence of GERD-related sleep disturbance in minimally-symptomatic subjects with demonstrated insomnia.

The research team assessed the changes in sleep efficiency in these subjects after vigorous acid suppression.

The team recruited subjects aged 18 to 75 years reporting at least 6 months of insomnia, and sleep difficulty at least 3 nights per week.

Subjects with a body mass index over 30, a history of snoring or ongoing use of proton pump inhibitor or H2 receptor antagonist were excluded.

The team reported that subjects underwent concurrent a sleep study with a dual channel 24-hour pH study.

Sleep efficiency was defined as the percentage of time after sleep initiation that the subject actually slept.

Spontaneous arousal index, defined as the number of arousals per hour, were calculated.

Patients demonstrating poor sleep quality had a sleep efficiency of less than 83%, and more than 10 arousals per hour for those aged under 45 years, and more than 15 for those who were 45 or older.

Patients with poor sleep quality and no obstructive sleep apnea were treated with oral rabeprazole 20 mg BID for 14 days.

The researchers reported that after 14 days, the subjects underwent repeat sleep study with pH monitoring.

The GERD Symptom Assessment Scale, the Epworth Sleepiness Scale, and the Functional Outcomes of Sleep Questionnaire were administered to subjects at study inception and after 2 weeks of therapy.

The researchers enrolled 24 subjects reporting insomnia, and 20 met criteria for disordered sleep and no obstructive sleep apnea.

The team noted that 17 patients completed both the first and second studies, and 16 were adequate for analysis.

Baseline Symptom Assessment Scale demonstrated trivial or no reflux symptoms in the cohort.

No subject scored more than 8 out of 45 on Symptom Assessment Scale, corresponding to a median rating of reflux symptoms of ‘not at all'.

The research team observed that 25% of patients demonstrated abnormal pH studies at baseline.

All of these patients had normalization of acid exposures on proton pump inhibitor.

The team noted that after 2 weeks of treatment, 19% had normalization of sleep efficiency.

However, 33% of patients with normal Johnson-DeMeester scores had normalization of sleep efficiency after 2 weeks of treatment.

Repeated measures analysis showed significant improvement in spontaneous arousal index between the first and second study for the whole group.

Pre- and post-therapy Epworth Sleepiness Scale, and Functional Outcomes of Sleep Questionnaire scores were not significantly different.

Dr Shaheen's team concluded, "Despite the lack of GERD symptoms, a significant minority of subjects with sleep disturbance have abnormal acid exposures."

"These preliminary data suggest that aggressive treatment of GERD in such patients may result in improvement in sleep efficiency."

Dig Dis Sci 2008: 53(6): 1493-9
12 May 2008

Go to top of page Email this page Email this page to a colleague

 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Management of hemorrhoids in the USA
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis
 26 January 2018 
Optimizing selection of biologics in IBD
 26 January 2018 
Nutritional risk and laparoscopic-assisted gastrectomy outcomes
 25 January 2018 
Patient-reported outcome measure for functional dyspepsia
 25 January 2018 
Predicting intra-abdominal infections after colorectal surgery
 25 January 2018 
Predictors of gastric cancer risk
 24 January 2018 
Risk factors underlying previously undiagnosed cirrhosis
 24 January 2018 
Ethnicity influences phenotype in IBD
 24 January 2018 
Bariatric surgery vs medical obesity treatment
 23 January 2018 
Atrophic gastritis after H. pylori eradication
 23 January 2018 
Ectopic pregnancy in women with IBD
 23 January 2018 
Celiac disease in IBS in the USA
 22 January 2018 
Improving symptoms in GERD
 22 January 2018 
Costs of biologic therapies for IBD in the USA
 22 January 2018 
Western vs Asian guidelines for colon cancer management

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us